Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan T M Huneke

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 10, 2022
Is superiority to placebo the most appropriate measure of efficacy in trials of novel psychotropic medications?Nathan T M Huneke
The British Journal of Psychiatry : the Journal of Mental Science|December 3, 2015
Does previous experience of antidepressants form the expectations necessary for a placebo response?Nathan T M Huneke, David S Baldwin
The British Journal of Psychiatry : the Journal of Mental Science|August 19, 2025
Efficacy and safety of an alpha 7-nicotinic acetylcholine receptor agonist, VQW-765, in subjects with performance anxiety: randomised, double-blind, placebo-controlled trial: commentary, Baldwin et alDavid S Baldwin, Nathan T M Huneke
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 1, 2025
Toward rigorous control conditions in trials of digital therapeuticsNathan T M Huneke, Blanca Bolea-Alamañac
JAMA Psychiatry|April 16, 2025
Understanding Placebo Mechanisms to Reduce Attrition in Psychiatric TrialsNathan T M Huneke, Samuele Cortese, Marco Solmi
Acta Psychiatrica Scandinavica|August 10, 2024
The relationship between blinding integrity and medication efficacy in randomised-controlled trials in patients with anxiety disorders: A systematic review and meta-analysisRuqayyah Haq, Laura Molteni, Nathan T M Huneke
Journal of Intellectual Disabilities : JOID|October 10, 2012
Difficult decisions: are intellectually disabled patients given enough information to consent to medical treatment?Nathan T M Huneke, Rupa Gupta, Neel Halder, et al.
Plos One|September 4, 2025
Detection of social anxiety using multiple simultaneous biosignals: A pilot studyChristoph Tremmel, Nathan T M Huneke, Daniel Hobson, et al.
Psychiatry Research|May 13, 2026
Perceived treatment assignment influences the effects of transcranial direct current stimulation on anxiety during an internet-based psychosocial stressorJoshua Hyde, Nathan T M Huneke, David S Baldwin, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 7, 2024
Systematic Review: Assessment of Blinding Integrity in 161 Randomized Controlled Trials of Medications for Attention-Deficit/Hyperactivity DisorderGuilherme Fusetto Veronesi, Nathan T M Huneke, Mohammad Shah, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 10, 2022
Is superiority to placebo the most appropriate measure of efficacy in trials of novel psychotropic medications?Nathan T M Huneke
The British Journal of Psychiatry : the Journal of Mental Science|December 3, 2015
Does previous experience of antidepressants form the expectations necessary for a placebo response?Nathan T M Huneke, David S Baldwin
The British Journal of Psychiatry : the Journal of Mental Science|August 19, 2025
Efficacy and safety of an alpha 7-nicotinic acetylcholine receptor agonist, VQW-765, in subjects with performance anxiety: randomised, double-blind, placebo-controlled trial: commentary, Baldwin et alDavid S Baldwin, Nathan T M Huneke
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 1, 2025
Toward rigorous control conditions in trials of digital therapeuticsNathan T M Huneke, Blanca Bolea-Alamañac
JAMA Psychiatry|April 16, 2025
Understanding Placebo Mechanisms to Reduce Attrition in Psychiatric TrialsNathan T M Huneke, Samuele Cortese, Marco Solmi
Acta Psychiatrica Scandinavica|August 10, 2024
The relationship between blinding integrity and medication efficacy in randomised-controlled trials in patients with anxiety disorders: A systematic review and meta-analysisRuqayyah Haq, Laura Molteni, Nathan T M Huneke
Journal of Intellectual Disabilities : JOID|October 10, 2012
Difficult decisions: are intellectually disabled patients given enough information to consent to medical treatment?Nathan T M Huneke, Rupa Gupta, Neel Halder, et al.
Plos One|September 4, 2025
Detection of social anxiety using multiple simultaneous biosignals: A pilot studyChristoph Tremmel, Nathan T M Huneke, Daniel Hobson, et al.
Psychiatry Research|May 13, 2026
Perceived treatment assignment influences the effects of transcranial direct current stimulation on anxiety during an internet-based psychosocial stressorJoshua Hyde, Nathan T M Huneke, David S Baldwin, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 7, 2024
Systematic Review: Assessment of Blinding Integrity in 161 Randomized Controlled Trials of Medications for Attention-Deficit/Hyperactivity DisorderGuilherme Fusetto Veronesi, Nathan T M Huneke, Mohammad Shah, et al.
Pageof 4